Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'cpp1 7 npy19 23 ala31 aib32 gln34 hpancreatic polypeptide'

Search results for: 'cpp1 7 npy19 23 ala31 aib32 gln34 hpancreatic polypeptide'

Items 1-10 of 13

Page
per page
  1. FT-207 (NSC 148958)
    B1474 FT-207 (NSC 148958)
    Summary: DNA/RNA synthesis inhibitor
      ≥100 mg/mL
  2. Ellipticine
    B7382 Ellipticine
    Target: Topoisomerases
    Summary: DNA topoisomerase II inhibitor
      ≥24.6 mg/mL
  3. Veliparib dihydrochloride
    A3958 Veliparib dihydrochloride
    Target: PARP
    Summary: PARP-1/PARP-2 inhibitor
      ≥31.7 mg/mL
  4. Mitomycin C
    A4452 Mitomycin C
     3 Citation
    Summary: Inhibits DNA synthesis,antibiotic and antitumor agent
      insoluble in H2O; insoluble in EtOH; ≥16.7 mg/mL
  5. Panobinostat (LBH589)
    A8178 Panobinostat (LBH589)
     10 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC inhibitor
      insoluble in H2O; insoluble in EtOH; ≥17.47 mg/mL
  6. Romidepsin (FK228, depsipeptide)
    A8173 Romidepsin (FK228, depsipeptide)
     7 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC1/HDAC2 inhibitor, potent and selective
      ≥27.04 mg/mL
  7. M344
    A4105 M344
     1 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC inhibitor,potent and cell-permeable
  8. (S)-10-Hydroxycamptothecin
    B4745 (S)-10-Hydroxycamptothecin
    Target: Topoisomerases
    Summary: inhibitor of topoisomerase I
      ≥23.8 mg/mL
  9. Daun02
    A3352 Daun02
     2 Citation
    Summary: Cell viability inhibitor,DNA synthisis inhibitor
      insoluble in H2O; insoluble in EtOH; ≥17.92 mg/mL
  10. PCI-24781 (CRA-024781)
    A4098 PCI-24781 (CRA-024781)
    Target: Histone Deacetylases (HDACs)
    Summary: Pan-HDAC inhibitor
      insoluble in H2O; insoluble in EtOH; ≥11.75 mg/mL

Items 1-10 of 13

Page
per page